Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications, Infectious | 6 | 2024 | 496 | 1.910 |
Why?
|
| Anti-HIV Agents | 4 | 2024 | 347 | 1.800 |
Why?
|
| HIV Infections | 8 | 2024 | 2049 | 1.750 |
Why?
|
| Ultrasonography, Prenatal | 6 | 2019 | 1009 | 0.940 |
Why?
|
| Pregnancy | 19 | 2024 | 7536 | 0.830 |
Why?
|
| Amniotic Band Syndrome | 3 | 2019 | 24 | 0.830 |
Why?
|
| Limb Deformities, Congenital | 2 | 2019 | 112 | 0.740 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 155 | 0.700 |
Why?
|
| Genomic Instability | 2 | 2020 | 246 | 0.690 |
Why?
|
| Prenatal Care | 2 | 2021 | 359 | 0.670 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2020 | 53 | 0.660 |
Why?
|
| Gynecology | 1 | 2021 | 129 | 0.660 |
Why?
|
| Community Health Services | 1 | 2021 | 92 | 0.650 |
Why?
|
| Carpal Bones | 1 | 2019 | 6 | 0.650 |
Why?
|
| DNA Repair Enzymes | 1 | 2020 | 43 | 0.630 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2020 | 95 | 0.630 |
Why?
|
| Thumb | 1 | 2019 | 30 | 0.630 |
Why?
|
| Radius | 1 | 2019 | 36 | 0.630 |
Why?
|
| Labor Stage, Second | 1 | 2019 | 16 | 0.620 |
Why?
|
| Dystocia | 1 | 2019 | 24 | 0.620 |
Why?
|
| HIV-1 | 1 | 2023 | 484 | 0.610 |
Why?
|
| Obstetrics | 1 | 2021 | 240 | 0.600 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 3086 | 0.540 |
Why?
|
| DNA | 2 | 2020 | 1478 | 0.520 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 491 | 0.520 |
Why?
|
| DNA Repair | 1 | 2020 | 567 | 0.500 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 480 | 0.490 |
Why?
|
| Infectious Disease Transmission, Vertical | 5 | 2024 | 253 | 0.430 |
Why?
|
| Sharks | 2 | 2024 | 4 | 0.370 |
Why?
|
| Female | 23 | 2024 | 70691 | 0.360 |
Why?
|
| Breast Feeding | 2 | 2023 | 233 | 0.360 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 1993 | 0.350 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 2023 | 98 | 0.350 |
Why?
|
| Viral Load | 2 | 2024 | 408 | 0.340 |
Why?
|
| HIV | 2 | 2020 | 190 | 0.300 |
Why?
|
| Humans | 26 | 2024 | 132055 | 0.280 |
Why?
|
| Chorionic Villi Sampling | 4 | 2019 | 46 | 0.280 |
Why?
|
| Amniocentesis | 4 | 2019 | 77 | 0.270 |
Why?
|
| Microarray Analysis | 4 | 2019 | 236 | 0.260 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 260 | 0.260 |
Why?
|
| Anti-Retroviral Agents | 2 | 2024 | 150 | 0.240 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2022 | 170 | 0.230 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2024 | 40 | 0.220 |
Why?
|
| Spinal Nerve Roots | 1 | 2024 | 19 | 0.220 |
Why?
|
| Ships | 1 | 2024 | 7 | 0.220 |
Why?
|
| Rhizotomy | 1 | 2024 | 18 | 0.220 |
Why?
|
| Conservation of Natural Resources | 1 | 2024 | 21 | 0.220 |
Why?
|
| Muscle Spasticity | 1 | 2024 | 61 | 0.210 |
Why?
|
| Texas | 2 | 2023 | 3632 | 0.200 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2023 | 12 | 0.200 |
Why?
|
| Trisomy 13 Syndrome | 2 | 2019 | 19 | 0.200 |
Why?
|
| Cerebral Palsy | 1 | 2024 | 85 | 0.200 |
Why?
|
| Pre-Eclampsia | 2 | 2023 | 230 | 0.200 |
Why?
|
| Developed Countries | 1 | 2023 | 42 | 0.200 |
Why?
|
| Arthrogryposis | 2 | 2019 | 39 | 0.200 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1966 | 0.190 |
Why?
|
| Maternal Exposure | 1 | 2023 | 156 | 0.180 |
Why?
|
| Social Justice | 1 | 2021 | 65 | 0.180 |
Why?
|
| Obstetric Labor Complications | 1 | 2022 | 98 | 0.170 |
Why?
|
| Sustained Virologic Response | 1 | 2021 | 46 | 0.170 |
Why?
|
| Community Health Centers | 1 | 2021 | 38 | 0.170 |
Why?
|
| Genetic Testing | 4 | 2019 | 1098 | 0.170 |
Why?
|
| Postnatal Care | 1 | 2021 | 52 | 0.170 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8539 | 0.170 |
Why?
|
| Prone Position | 1 | 2020 | 33 | 0.170 |
Why?
|
| Reproductive Health | 1 | 2020 | 49 | 0.160 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2019 | 3 | 0.160 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2019 | 7 | 0.160 |
Why?
|
| Clubfoot | 1 | 2019 | 21 | 0.160 |
Why?
|
| Patient Positioning | 1 | 2020 | 56 | 0.160 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2019 | 16 | 0.160 |
Why?
|
| Retrospective Studies | 6 | 2024 | 17367 | 0.160 |
Why?
|
| Polydactyly | 1 | 2019 | 18 | 0.160 |
Why?
|
| Social Stigma | 1 | 2020 | 85 | 0.160 |
Why?
|
| Fanconi Anemia | 1 | 2019 | 39 | 0.160 |
Why?
|
| Anal Canal | 1 | 2019 | 82 | 0.160 |
Why?
|
| Nucleic Acid Conformation | 1 | 2020 | 182 | 0.150 |
Why?
|
| Models, Molecular | 2 | 2020 | 1119 | 0.150 |
Why?
|
| Tuna | 1 | 2019 | 1 | 0.150 |
Why?
|
| Animal Migration | 1 | 2019 | 14 | 0.150 |
Why?
|
| Postpartum Period | 1 | 2021 | 231 | 0.150 |
Why?
|
| Perciformes | 1 | 2019 | 9 | 0.150 |
Why?
|
| Extremities | 1 | 2019 | 84 | 0.150 |
Why?
|
| Spine | 1 | 2019 | 147 | 0.150 |
Why?
|
| Population Dynamics | 1 | 2019 | 34 | 0.150 |
Why?
|
| Valproic Acid | 1 | 2019 | 163 | 0.150 |
Why?
|
| Thermus thermophilus | 1 | 2018 | 11 | 0.150 |
Why?
|
| Ions | 1 | 2018 | 22 | 0.150 |
Why?
|
| Disulfides | 1 | 2018 | 82 | 0.150 |
Why?
|
| Morbidity | 1 | 2019 | 253 | 0.150 |
Why?
|
| Hypoxia | 1 | 2020 | 259 | 0.150 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 127 | 0.140 |
Why?
|
| Copper | 1 | 2018 | 75 | 0.140 |
Why?
|
| DNA Sequence, Unstable | 1 | 2018 | 2 | 0.140 |
Why?
|
| Ecosystem | 1 | 2019 | 107 | 0.140 |
Why?
|
| Trachea | 1 | 2019 | 210 | 0.140 |
Why?
|
| Esophagus | 1 | 2019 | 234 | 0.140 |
Why?
|
| Anemia | 1 | 2022 | 350 | 0.140 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 233 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2023 | 5168 | 0.140 |
Why?
|
| Premature Birth | 1 | 2022 | 418 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2023 | 551 | 0.130 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 416 | 0.130 |
Why?
|
| Models, Genetic | 1 | 2020 | 770 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2020 | 698 | 0.130 |
Why?
|
| DNA Damage | 1 | 2020 | 511 | 0.130 |
Why?
|
| United States | 3 | 2021 | 11652 | 0.130 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 248 | 0.120 |
Why?
|
| Cesarean Section | 1 | 2019 | 407 | 0.120 |
Why?
|
| Adult | 5 | 2024 | 31557 | 0.120 |
Why?
|
| Fetoscopy | 1 | 2019 | 448 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 389 | 0.110 |
Why?
|
| Cell Line | 1 | 2020 | 2723 | 0.110 |
Why?
|
| Neoplasms | 2 | 2020 | 2952 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 982 | 0.100 |
Why?
|
| Infant | 3 | 2023 | 13037 | 0.100 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 930 | 0.100 |
Why?
|
| Kidney | 1 | 2019 | 1338 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2023 | 1253 | 0.100 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 1866 | 0.090 |
Why?
|
| Ciliary Motility Disorders | 2 | 2019 | 13 | 0.080 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2019 | 33 | 0.080 |
Why?
|
| Encephalocele | 2 | 2019 | 48 | 0.080 |
Why?
|
| Retinitis Pigmentosa | 2 | 2019 | 96 | 0.070 |
Why?
|
| Mutation | 2 | 2020 | 6246 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 381 | 0.070 |
Why?
|
| Child | 3 | 2024 | 25758 | 0.060 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2024 | 34 | 0.060 |
Why?
|
| Muscle Relaxants, Central | 1 | 2024 | 39 | 0.050 |
Why?
|
| Endangered Species | 1 | 2024 | 13 | 0.050 |
Why?
|
| Baclofen | 1 | 2024 | 45 | 0.050 |
Why?
|
| Amides | 1 | 2024 | 91 | 0.050 |
Why?
|
| Pyridones | 1 | 2024 | 130 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2024 | 90 | 0.050 |
Why?
|
| North America | 1 | 2023 | 265 | 0.050 |
Why?
|
| Efficiency | 1 | 2023 | 67 | 0.050 |
Why?
|
| Piperazines | 1 | 2024 | 255 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 1 | 2023 | 124 | 0.050 |
Why?
|
| Canada | 1 | 2023 | 337 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2024 | 634 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 313 | 0.040 |
Why?
|
| Milk, Human | 1 | 2023 | 308 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 2020 | 85 | 0.040 |
Why?
|
| Pallister-Hall Syndrome | 1 | 2019 | 3 | 0.040 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2019 | 8 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 5013 | 0.040 |
Why?
|
| Breech Presentation | 1 | 2019 | 20 | 0.040 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 22 | 0.040 |
Why?
|
| Pierre Robin Syndrome | 1 | 2019 | 29 | 0.040 |
Why?
|
| Bone Diseases, Developmental | 1 | 2019 | 60 | 0.040 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2019 | 47 | 0.040 |
Why?
|
| Oligohydramnios | 1 | 2019 | 48 | 0.040 |
Why?
|
| Cuba | 1 | 2019 | 7 | 0.040 |
Why?
|
| Oceans and Seas | 1 | 2019 | 11 | 0.040 |
Why?
|
| Iron | 1 | 2022 | 302 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 323 | 0.040 |
Why?
|
| Solvents | 1 | 2018 | 44 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 65 | 0.040 |
Why?
|
| Mexico | 1 | 2019 | 185 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 563 | 0.040 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 149 | 0.040 |
Why?
|
| Streptococcus agalactiae | 1 | 2019 | 103 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2018 | 83 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 128 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 311 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 436 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 661 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2019 | 289 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 299 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 1130 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2018 | 825 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2024 | 14719 | 0.030 |
Why?
|
| DNA Replication | 1 | 2018 | 353 | 0.030 |
Why?
|
| Amino Acids | 1 | 2018 | 626 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 1255 | 0.030 |
Why?
|
| Decision Making | 1 | 2020 | 695 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 631 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1731 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 2669 | 0.030 |
Why?
|
| Male | 3 | 2024 | 64944 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 1718 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1185 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2019 | 1699 | 0.020 |
Why?
|
| Lung | 1 | 2020 | 1556 | 0.020 |
Why?
|
| Animals | 2 | 2024 | 34823 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 13015 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3852 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2551 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 9938 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 20530 | 0.020 |
Why?
|